Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: a final report of CALGB 9780. Cancer and Leukemia Group B. (Q43594181)
scientific article
Language:
Current Data About Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: a final report of CALGB 9780. Cancer and Leukemia Group B.
(P31) (Q13442814)
(P248)
(P698) 11331330
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11331330%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, November 7, 2019

(P50) (Q42896002)
(P1545) 2
(P248)
(P698) 11331330
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11331330%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, November 7, 2019

(Q97531370)
(P1545) 8
(P1932) E J Small
(P248)
(P698) 11331330
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11331330%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, November 7, 2019

(P304) 2509-2516
(P248)
(P698) 11331330
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11331330%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, November 7, 2019

(P407) (Q1860)

(P433) 9
(P248)
(P698) 11331330
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11331330%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, November 7, 2019

(P478) 19
(P248)
(P698) 11331330
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11331330%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, November 7, 2019

(P577) Tuesday, May 1, 2001
(P248)
(P698) 11331330
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11331330%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, November 7, 2019

(P921) (Q29496)
(P887)

(Q181257)
(P887)

(Q26981430)
(P887)

(Q420436)
(P887)

(P1433) (Q400292)
(P248)
(P698) 11331330
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11331330%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, November 7, 2019

(P1476) "Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: a final report of CALGB 9780. Cancer and Leukemia Group B" (language: en)
(P248)
(P698) 11331330
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11331330%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, November 7, 2019

(P2093) D M Savarese
(P1545) 1
(P248)
(P698) 11331330
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11331330%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, November 7, 2019

V Hars
(P1545) 3
(P248)
(P698) 11331330
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11331330%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, November 7, 2019

W L Akerley
(P1545) 4
(P248)
(P698) 11331330
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11331330%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, November 7, 2019

M E Taplin
(P1545) 5
(P248)
(P698) 11331330
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11331330%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, November 7, 2019

P A Godley
(P1545) 6
(P248)
(P698) 11331330
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11331330%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, November 7, 2019

A Hussain
(P1545) 7
(P248)
(P698) 11331330
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11331330%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, November 7, 2019

N J Vogelzang
(P1545) 9
(P248)
(P698) 11331330
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11331330%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, November 7, 2019

other details
description scientific article

External Links
(P356) 10.1200/JCO.2001.19.9.2509
(P698) 11331330